Qlucore (QCORE.ST) Stock Analysis & AI Equity Report
Qlucore (QCORE.ST) overview
Qlucore (QCORE.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, Qlucore reported revenue of SEK 6.7m and operating profit of SEK -28.0m; the year-end share price was 0.47 SEK and market capitalisation was SEK 13.9m. Qlucore is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Qlucore's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-27. Data will be refreshed during report generation.
About Qlucore
Qlucore develops software for visualizing and analyzing complex biological data, with products used in life science, biotechnology and clinical research. Its main offering, Qlucore Omics Explorer, supports multi-omics and NGS analysis through interactive visualization, statistical tools and machine-learning based classifiers, while Qlucore also provides software for precision and companion diagnostics.
Generate the Qlucore report
Qlucore is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Qlucore and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.